PNC
IBB icon

Point Nemo Capital’s iShares Biotechnology ETF IBB Stock Holding History

Point Nemo Capital’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$969K Buy
+5,097
New +$876K 0.49% 83
2026
Q1 		– Sell
-2,594
Closed -$438K – 108
2025
Q4 		$438K Buy
+2,594
New +$421K 0.43% 93

Other funds holding IBB

Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Point Nemo Capital's IBB Position: Q2 2026 in Review

Point Nemo Capital opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 5,097 shares worth $969K. The stake represents 0.49% of the portfolio and ranks #83 among its holdings. This is a return to the name: Point Nemo Capital previously reported a position in IBB as recently as Q4 2025.

Point Nemo Capital first reported a position in IBB in Q4 2025 and has held it in 2 quarters since. 926 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Point Nemo Capital held 5,097 shares of iShares Biotechnology ETF worth $969K as of Q2 2026.
  • iShares Biotechnology ETF was a new Point Nemo Capital position in Q2 2026.
  • iShares Biotechnology ETF made up 0.49% of Point Nemo Capital's portfolio in Q2 2026, its #83 holding.
  • Point Nemo Capital first reported a position in iShares Biotechnology ETF in Q4 2025 and has held it in 2 quarters since.
  • 926 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Point Nemo Capital's 13F filing for Q2 2026, filed 7 Aug 2026.